Sales/Profit and loss

The Group has been actively engaged in the healthcare business and the school DX business, both of which are expected to expand in the future, in order to enhance its corporate value over the medium- to long-term.
During the current fiscal year under review, consolidated net sales increased to ¥29,910 million (up 8.1% year-on-year), mainly due to sales growth in the healthcare and school DX businesses, and gross profit increased to ¥22,223 million (up 8.9% year-on-year) due to higher net sales.
Operating income increased to ¥2,946 million (up 23.1% year-on-year), as the rise in gross profit more than offset the increase in selling, general and administrative expenses, which was mainly due to higher advertising and promotion expenses.
Ordinary income increased to ¥3,027 million (up 7.1% year-on-year). In the previous fiscal year, equity in earnings of affiliates amounted to ¥534 million, mainly reflecting a special gain recorded by Shobunsha Holdings,Inc., an equity-method affiliate. In the current fiscal year, equity in earnings of affiliates totaled ¥107 million, resulting in only a modest increase in ordinary income.
Profit attributable to owners of parent increased significantly to ¥3,404 million (up 44.0% year-on-year), mainly due to a substantial increase in special gains associated with refunded consumption tax and a decrease in income tax adjustments resulting from the recognition of deferred tax assets at consolidated subsidiaries.

(Millions of yen)